Skip to content

HHT Frontlines – Scientific Newsletter

Spring 2022. Cure HHT’s biannual newsletter that centralizes and summarizes select and important publications about HHT for patients, clinicians, and scientists. Topic areas: Tacrolimus nasal ointment, topical propranolol, pazopanib, itraconazol, sclerotherapy with cautery/laser treatment, and more. View as flipbook or click “download resource” button to view pdf.

Related Resources

Webinar

Bedside to Bench: How the HHT Community Drives Research Initiatives (Recorded)
Webinar

Nuts and Bolts of A Clinical Trial – the PATH-HHT Study (Recorded)
Scientific Literature

Screening for pulmonary and brain vascular malformations is the North American standard of care for patients with hereditary hemorrhagic telangiectasia (HHT): A survey of HHT Centers of Excellence
Scroll To Top